Influence of four different PTH methods on the classification of chronic kidney disease patients according to the new KDIGO guideline

Clinical Laboratory

Volumn 58, Issue 7-8, 2012, Pages 719-724

  Ten Boekel, Edwin ^a   Van Veen, Merk C ^c   Vervloet, Marc G ^d   Fischer, Johan C ^b   Koopman, Marion G ^b   Van Dam, Bastiaan ^c  

^a Medical Centre Alkmaar   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Department of Internal Medicine   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

KDIGO; KDOQI; PTH assays; Secondary hyperparathyroidism

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE;

GUIDELINES AS TOPIC; HUMANS; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE;

EID: 84866141044     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.110631     Document Type: Article

References (12)

1. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;69:1945-53.
2. Salgueira M, Del Toro N, Moreno-Alba R, et al. Vascular calcification in the uremic patient: a cardiovascular risk? Kidney Int 2003;63:S119-S121.
3. Eddington H, Sinha S, Kalra PA. Vascular calcification in chronic kidney disease: a clinical review. J Ren Care 2009;35:45-50.
4. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 20003;42:S1-201.
5. Souberbielle JC, Boutten A, Carlier MC, et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006;70:345-50.
6. Joly D, Drueke TB, Alberti C, et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis 2008;51:987-95.
7. Monge M, Jean G, Bacr JL, et al. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods. Clin Chem Lab Med 2009;47:362-6.
8. KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease - mineral and bone disorder (CKD-MBD). Kidney Int 2009;76:S1-121.
9. Souberbielle JC, Cavalier E, Jean G. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory? Clin Chem Lab Med 2010;48:769-74.
10. Clinical and Laboratory Standards Institute (CLSI). Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline - Third Edition" (C28-A3). Wayne, PA. 2008;28 (30).
11. Fillée C, Allaeys JM, Delait AM, et al. Intra-operative and routine intact parathyroid hormone assay on the Beckman Coulter Unicel® DxI 800. Endocr. Abstracts 2008;16:P84.
12. Reinmark L, Vestergaard P, Heickendorff L, et al. Determinants of plasma PTH and their implication for defining a reference interval. Clin. Endocrinol. 2011;74:37-43.